Funding & VC

IGEL exceeds $1 billion valuation with Vitruvian investment

Vitruvian Partners’ undisclosed investment pushes endpoint security vendor IGEL past a $1 billion valuation and joins TA Associates ahead of an expected Q1 2027 close.

By Nathan Brooks

3 min read

IGEL Reaches $1 Billion Valuation With Vitruvian Investment
IGEL Reaches $1 Billion Valuation With Vitruvian InvestmentPexels / pixabay

What's News

  • IGEL's valuation exceeds $1 billion after Vitruvian Partners' strategic investment.
  • Vitruvian Partners and TA Associates expect the transaction to close in Q1 2027, subject to regulatory approvals.
  • IGEL reported annual recurring revenue growth above 40% during the past year.
  • TA Associates first invested in IGEL in 2021.
  • The investment amount, ownership stake and other financial terms were not disclosed.

By Nathan Brooks

IGEL has reached a valuation exceeding $1 billion after Vitruvian Partners agreed to make a strategic investment. Vitruvian will join existing investor TA Associates in supporting the endpoint security software company's product development and international expansion.

The companies did not disclose the investment amount or other financial terms. Vitruvian Partners and TA Associates expect the deal to close during the first quarter of 2027, subject to regulatory approvals.

The $1 billion figure is IGEL's company valuation, not the size of Vitruvian's investment. The announcement leaves the stake and post-money ownership split undisclosed.

Klaus Oestermann, CEO of IGEL, said:

“Enterprises and governments need a trusted endpoint platform that helps them prevent disruption and keep their businesses operating. Our growing adoption by large international enterprises and governments demonstrates both the strength of our technology and the scale of the opportunity ahead.”

He added:

“Together with Vitruvian and TA, we believe we are positioned to accelerate our global expansion and establish IGEL as an essential platform for enterprises and entire countries’ security and resilience strategy.”

What does this change for enterprise IT teams?

Vitruvian's backing gives IGEL additional institutional support for product development and international growth. For IT buyers, the practical change is more expansion capacity around the existing platform, not a newly announced product.

IGEL says its platform covers preventative security, business continuity, disaster recovery and operational technology. It starts with an immutable operating system intended to limit the endpoint attack surface and reduce local data exposure. Centralized governance and contextual controls support access to cloud services, virtual desktops, enterprise browsers, software-as-a-service applications and other compatible systems.

For supported Windows endpoints affected by ransomware, outages or other disruptions, IGEL's business-continuity and disaster-recovery technology provides a recovery path. The company also applies its security and centralized-management model to manufacturing and operational environments where availability is critical.

IGEL reported annual recurring revenue growth exceeding 40% during the past year. On a $100 starting base, that pace produces more than $140. IGEL plans to invest in product innovation, partner development and global expansion.

Jack Alcock, Partner at Vitruvian Partners, said:

“IGEL sits at the center of a structural shift in enterprise cybersecurity. As the threat landscape continues to evolve, enterprises are increasingly seeing immutable endpoints as a critical component of their Zero Trust strategy.”

He continued:

“With its leading product suite across endpoint OS, BC&DR and OT, we believe IGEL has a unique opportunity to capitalize on these tailwinds.”

Tassilo Arnhold, Partner at Vitruvian Partners, said:

“With its mission-critical software and its exceptional leadership team, IGEL is well-placed to continue its global expansion. Vitruvian brings extensive experience of supporting European market leaders in their global ambitions and we look forward to working with Klaus and his team, alongside TA, to accelerate the Company’s international growth.”

Stefan Dandl, Managing Director at TA Associates, and John Meeks, Senior Advisor at TA Associates, said:

“Since TA’s initial investment in 2021, IGEL has expanded its platform, increased operational and developmental bandwidth, and strengthened its global presence. In a time of rapid digital transformation, we remain confident in IGEL’s strategy and its ability to help customers modernize securely.”

They added:

“We are pleased to welcome Vitruvian and look forward to working together alongside IGEL management to support IGEL’s continued growth journey.”

For enterprise customers, the investment changes the resources behind IGEL's international buildout, while the platform scope remains as described. The next hard checkpoint is regulatory clearance and the first-quarter 2027 close, after which IGEL will have additional backing for the product, partner and global expansion priorities it has set.

Source: pulse2.com

Share this article:

More from Nathan Brooks

Nathan Brooks

Show full bio

News editor covering regulation, policy and their impact on entrepreneurship, startups and venture funding at Business Bearings.

2,492 articles

Related articles

« Previous articleNext article »